FAN1 (Fanconi-associated nuclease 1) variants and mutations
FAN1 (also known as Fanconi-associated nuclease 1) is a human protein-coding gene encoding a fanconi-associated nuclease 1 protein. It processes branched and damaged DNA structures and contributes to repair of interstrand crosslinks and stalled replication intermediates. Biallelic pathogenic variants cause karyomegalic interstitial nephritis, while repeat-length variation in FAN1 modifies age at onset of some repeat-expansion diseases. This analysis covers 1,677 FAN1 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes karyomegalic interstitial nephritis, hereditary disease, and chronic kidney disease. Example FAN1 variants include M1?, M1V, and M2I.
Variant analysis overview
- Gene: FAN1
- Protein: Fanconi-associated nuclease 1
- UniProt accession: Q9Y2M0
- Organism: Homo sapiens
- Variants analyzed: 1677
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 1,187 unspecified-consequence records; 172 synonymous variants; 20 in-frame deletions; 228 missense variants; 61 frameshift variants; 7 stop-gained variants; 1 in-frame insertions; 1 substitution
- Prediction scores: 1,373 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: karyomegalic interstitial nephritis, hereditary disease, chronic kidney disease, Abnormality of the skeletal system, interstitial nephritis, kidney failure, neurodegenerative disease, skin neoplasm, Tietze syndrome, benign neoplasm of eye, hereditary breast ovarian cancer syndrome, Hereditary breast and ovarian cancer syndrome.
Protein structure and variant hotspots
- Protein features: 1 domains; 9 binding sites; 1 post-translational modification sites.
- Structural context: 114 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable FAN1 variants
Examples include M1?, M1V, M2I, M2L, M2T, S3*, S3L, S3S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, NCI-TCGA Cosmic COSV6294, cosmic curated COSV62949, Variant assessed as somatic; high impact.
- M1V (p.Met1Val), rs139312614, ClinGen CA7449949, ClinVar RCV001899896, ClinVar RCV002490003, Uncertain significance, not provided; Karyomegalic interstitial nephritis
- M2I (p.Met2Ile), rs2542568530, ClinGen CA391519486, ClinVar RCV004383693, Uncertain significance, Inborn genetic diseases
- M2L (p.Met2Leu), gnomAD rs1435694814, REVEL 0.49, CADD 22.50, Uncertain significance, Karyomegalic interstitial nephritis
- M2T (p.Met2Thr), rs143294144, ClinGen CA7449950, ClinVar RCV002921881, ClinVar RCV003973539, REVEL 0.52, CADD 21.60, Likely benign, not provided
- S3* (p.Ser3Ter), ExAC rs745548375, TOPMed rs745548375, gnomAD rs745548375, CADD 35.00
- S3L (p.Ser3Leu), ExAC rs745548375, TOPMed rs745548375, gnomAD rs745548375
- S3S (p.Ser3Ser), rs758119761, gnomAD 15-30904672-A-G, CADD 2.35
- E4D (p.Glu4Asp), Ensembl rs2061930114
- E4K (p.Glu4Lys), ESP rs369398471, ExAC rs369398471, TOPMed rs369398471, gnomAD rs369398471, REVEL 0.22, CADD 21.40, Uncertain significance, Inborn genetic diseases; Karyomegalic interstitial nephritis
- G5R (p.Gly5Arg), rs149291568, 1000Genomes rs149291568, ESP rs149291568, ExAC rs149291568, REVEL 0.06, CADD 17.90, Uncertain significance, Karyomegalic interstitial nephritis; not provided
- G5G (p.Gly5Gly), gnomAD 15-30904678-G-A, CADD 6.58
- K6R (p.Lys6Arg), TOPMed rs1447728881
- K6K (p.Lys6Lys), rs2061930381, gnomAD 15-30904681-A-G, CADD 4.59
- P7R (p.Pro7Arg), ExAC rs768704240
- P7S (p.Pro7Ser), TOPMed rs2061930451, REVEL 0.09, CADD 0.18
- P7L (p.Pro7Leu), gnomAD 15-30904683-C-T, REVEL 0.24, CADD 19.60
- P7H (p.Pro7His), gnomAD 15-30904683-C-A, REVEL 0.24, CADD 19.70
- P7P (p.Pro7Pro), gnomAD 15-30904684-T-C, CADD 2.62
- P8A (p.Pro8Ala), ExAC rs776542535, TOPMed rs776542535, gnomAD rs776542535, REVEL 0.22, CADD 5.25
- P8L (p.Pro8Leu), Ensembl rs751963671
- P8S (p.Pro8Ser), ExAC rs776542535, TOPMed rs776542535, gnomAD rs776542535, REVEL 0.09, CADD 5.41
- P8del (p.Pro8del), rs767783867, gnomAD 15-30904681-ACCT-, CADD 12.60
- P8P (p.Pro8Pro), rs1301466836, gnomAD 15-30904687-T-A, CADD 6.10
- D9E (p.Asp9Glu), TOPMed rs916700095, REVEL 0.13, CADD 0.04
- D9G (p.Asp9Gly), 1000Genomes rs560053916, TOPMed rs560053916, gnomAD rs560053916, REVEL 0.21, CADD 3.70
- D9Y (p.Asp9Tyr), gnomAD 15-30904688-G-T, REVEL 0.29, CADD 21.20
- D9D (p.Asp9Asp), gnomAD 15-30904690-C-T, CADD 1.81
- K10N (p.Lys10Asn), Ensembl rs1233415139
- K10R (p.Lys10Arg), gnomAD 15-30904692-A-G, REVEL 0.16, CADD 3.39
- K11R (p.Lys11Arg), TOPMed rs1373989201, gnomAD rs1373989201, REVEL 0.28, CADD 24.10
- K11G (p.Lys11Gly), rs752820596, gnomAD 15-30904690-CAAAA, CADD 26.60
- K11S (p.Lys11Ser), rs1160715785, gnomAD 15-30904694-AAAAG, CADD 27.80
- K11E (p.Lys11Glu), gnomAD 15-30904694-A-G, REVEL 0.38, CADD 26.50
- K11I (p.Lys11Ile), rs2061931290, gnomAD 15-30904694-A-AT, CADD 28.20
- R12K (p.Arg12Lys), rs752820596, gnomAD 15-30904690-C-CA, CADD 20.60
- R12G (p.Arg12Gly), rs752820596, gnomAD 15-30904690-CA-C, CADD 19.60
- R12del (p.Arg12del), gnomAD 15-30904695-AAAG-, CADD 17.90
- R12M (p.Arg12Met), gnomAD 15-30904698-G-T, REVEL 0.40, CADD 23.30
- R12S (p.Arg12Ser), gnomAD 15-30904699-G-T, REVEL 0.46, CADD 21.80
- P13A (p.Pro13Ala), TOPMed rs2061931437
- P13L (p.Pro13Leu), ExAC rs770014670, gnomAD rs770014670, REVEL 0.27, CADD 22.50, Uncertain significance, Karyomegalic interstitial nephritis
- P13R (p.Pro13Arg), ExAC rs770014670, gnomAD rs770014670, REVEL 0.29, CADD 23.40, Uncertain significance
- P13S (p.Pro13Ser), TOPMed rs2061931437, REVEL 0.20, CADD 21.60
- P13T (p.Pro13Thr), gnomAD 15-30904700-C-A, REVEL 0.21, CADD 23.00
- R14C (p.Arg14Cys), ExAC rs773502379, TOPMed rs773502379, gnomAD rs773502379, REVEL 0.16, CADD 22.70
- R14H (p.Arg14His), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, ExAC rs763284160, gnomAD rs763284160, REVEL 0.20, CADD 22.70, Variant assessed as somatic; moderate impact.
- R14L (p.Arg14Leu), ExAC rs763284160, gnomAD rs763284160, REVEL 0.33, CADD 23.70
- R14P (p.Arg14Pro), ExAC rs763284160, gnomAD rs763284160, REVEL 0.35, CADD 26.00
- R14S (p.Arg14Ser), NCI-TCGA Cosmic COSV6295, cosmic curated COSV62951, Variant assessed as somatic; moderate impact.
- R14V (p.Arg14Val), rs764248199, gnomAD 15-30904702-TC-T, CADD 23.40
- R14G (p.Arg14Gly), gnomAD 15-30904703-C-G, REVEL 0.32, CADD 22.40
- R14R (p.Arg14Arg), gnomAD 15-30904705-T-A, CADD 7.82
- R15G (p.Arg15Gly), ExAC rs766836928, TOPMed rs766836928, gnomAD rs766836928, REVEL 0.17, CADD 21.00
- R15R (p.Arg15Arg), rs766836928, gnomAD 15-30904706-A-C, CADD 12.90
- S16G (p.Ser16Gly), gnomAD rs1336635969, REVEL 0.43, CADD 26.00
- S16N (p.Ser16Asn), TOPMed rs1241425858, gnomAD rs1241425858, REVEL 0.38, CADD 23.80, Uncertain significance, Inborn genetic diseases
- S16R (p.Ser16Arg), ExAC rs774923094, gnomAD rs774923094, REVEL 0.44, CADD 23.20
- L17F (p.Leu17Phe), rs759933516, ClinGen CA7449968, cosmic curated COSV10591, ClinVar RCV003364809, REVEL 0.40, CADD 22.60, Uncertain significance, Inborn genetic diseases
- L17I (p.Leu17Ile), gnomAD 15-30904712-T-A, REVEL 0.33, CADD 23.90
- L17L (p.Leu17Leu), rs759933516, gnomAD 15-30904714-A-G, CADD 8.40
- S18* (p.Ser18Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S18S (p.Ser18Ser), gnomAD 15-30904717-A-G, CADD 6.79
- I19A (p.Ile19Ala), gnomAD 15-30904713-TATCA, CADD 24.80
- I19M (p.Ile19Met), gnomAD 15-30904720-C-G, REVEL 0.29, CADD 9.08
- I19I (p.Ile19Ile), gnomAD 15-30904720-C-A, CADD 7.29
- S20G (p.Ser20Gly), ExAC rs753170032, gnomAD rs753170032, REVEL 0.11, CADD 18.60
- S20I (p.Ser20Ile), NCI-TCGA Cosmic COSV6295, cosmic curated COSV62950, Variant assessed as somatic; moderate impact.
- K21E (p.Lys21Glu), TOPMed rs1282310638, gnomAD rs1282310638, REVEL 0.25, CADD 23.80
- K21N (p.Lys21Asn), NCI-TCGA Cosmic COSV6295, cosmic curated COSV62951, Variant assessed as somatic; moderate impact.
- K21T (p.Lys21Thr), TOPMed rs2061932420
- K21del (p.Lys21del), gnomAD 15-30904723-CAAG-, CADD 15.90
- K21K (p.Lys21Lys), rs756748584, gnomAD 15-30904726-G-A, CADD 7.90
- N22T (p.Asn22Thr), ExAC rs764729330, gnomAD rs764729330, REVEL 0.09, CADD 8.99
- K23Q (p.Lys23Gln), TOPMed rs1266926713, gnomAD rs1266926713, REVEL 0.09, CADD 21.00, Uncertain significance, Inborn genetic diseases
- K23R (p.Lys23Arg), Ensembl rs2061932661, REVEL 0.05, CADD 16.00
- K23* (p.Lys23Ter), gnomAD 15-30904729-T-TTA, CADD 23.50
- K24E (p.Lys24Glu), ExAC rs750016168, gnomAD rs750016168, REVEL 0.30, CADD 22.50
- K24N (p.Lys24Asn), NCI-TCGA Cosmic COSV6295, Variant assessed as somatic; moderate impact.
- K25S (p.Lys25Ser), rs750426078, gnomAD 15-30904732-GAA-G, CADD 25.90
- p.Lys25 Ala26delinsThr, rs1196253713, gnomAD 15-30904736-AAAG-, CADD 15.40
- A26P (p.Ala26Pro), ExAC rs758101202, gnomAD rs758101202, REVEL 0.25, CADD 16.70
- A26T (p.Ala26Thr), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, REVEL 0.17, CADD 15.00, Variant assessed as somatic; moderate impact.
- A26V (p.Ala26Val), gnomAD rs1454061107, REVEL 0.24, CADD 5.11
- A26S (p.Ala26Ser), gnomAD 15-30904732-G-GA, CADD 25.70
- A26H (p.Ala26His), rs2061932936, gnomAD 15-30904738-AG-A, CADD 23.20
- A26A (p.Ala26Ala), rs898428118, gnomAD 15-30904741-A-G, CADD 4.73
- S27F (p.Ser27Phe), rs139353520, ClinGen CA7449975, ClinVar RCV001864031, ClinVar RCV003956417, REVEL 0.22, CADD 17.40, Uncertain significance, not provided; Karyomegalic interstitial nephritis
- S27Y (p.Ser27Tyr), gnomAD 15-30904743-C-A, REVEL 0.13, CADD 16.10
- p.Asn28 Ser29del, gnomAD 15-30904741-ATCTA, CADD 12.30
- N28D (p.Asn28Asp), gnomAD 15-30904745-A-G, REVEL 0.18, CADD 13.90
- S29F (p.Ser29Phe), cosmic curated COSV10467, gnomAD rs199574217
- S29Y (p.Ser29Tyr), rs199574217, NCI-TCGA Cosmic COSV6295, gnomAD rs199574217, REVEL 0.52, CADD 24.20, Variant assessed as somatic; moderate impact.
- I30F (p.Ile30Phe), ExAC rs751410785, TOPMed rs751410785, gnomAD rs751410785, REVEL 0.55, CADD 24.10
- I30T (p.Ile30Thr), gnomAD rs1245504451, REVEL 0.60, CADD 24.60
- I30V (p.Ile30Val), ExAC rs751410785, TOPMed rs751410785, gnomAD rs751410785, REVEL 0.37, CADD 17.50
- I31M (p.Ile31Met), rs781134478, ClinGen CA235918, ClinVar RCV000171228, ClinVar RCV002470785, REVEL 0.16, CADD 15.40, Conflicting interpretations, not provided; Karyomegalic interstitial nephritis
- I31V (p.Ile31Val), gnomAD 15-30904754-A-G, REVEL 0.08, CADD 0.26
- S32L (p.Ser32Leu), rs748042109, ExAC rs748042109, TOPMed rs748042109, gnomAD rs748042109, REVEL 0.25, CADD 17.30, Uncertain significance, Inborn genetic diseases; Karyomegalic interstitial nephritis
- S32P (p.Ser32Pro), gnomAD 15-30904757-T-C, REVEL 0.50, CADD 22.20
- S32S (p.Ser32Ser), gnomAD 15-30904759-G-T, CADD 0.18
- C33Y (p.Cys33Tyr), gnomAD 15-30904761-G-A, REVEL 0.19, CADD 7.39
- F34C (p.Phe34Cys), TOPMed rs1475814624, REVEL 0.80, CADD 25.90, Uncertain significance, Karyomegalic interstitial nephritis
- F34I (p.Phe34Ile), TOPMed rs1190522763, gnomAD rs1190522763, REVEL 0.71, CADD 25.20
- F34L (p.Phe34Leu), gnomAD 15-30904761-GT-G, CADD 16.60
- F34S (p.Phe34Ser), gnomAD 15-30904764-T-C, REVEL 0.82, CADD 25.30
- F34F (p.Phe34Phe), gnomAD 15-30904765-T-C, CADD 9.19
- N35D (p.Asn35Asp), ExAC rs769939083, TOPMed rs769939083, gnomAD rs769939083, REVEL 0.35, CADD 23.30, Uncertain significance, Karyomegalic interstitial nephritis
- N35S (p.Asn35Ser), TOPMed rs1477870280, gnomAD rs1477870280, REVEL 0.35, CADD 11.90
- N36S (p.Asn36Ser), rs146249441, 1000Genomes rs146249441, ESP rs146249441, ExAC rs146249441, REVEL 0.25, CADD 14.50, Uncertain significance, Karyomegalic interstitial nephritis; not provided; Inborn genetic diseases
- N36N (p.Asn36Asn), gnomAD 15-30904771-T-C, CADD 7.94
- A37G (p.Ala37Gly), TOPMed rs1369996886, gnomAD rs1369996886
- A37V (p.Ala37Val), TOPMed rs1369996886, gnomAD rs1369996886, REVEL 0.19, CADD 0.08
- P38H (p.Pro38His), gnomAD 15-30904772-G-GCA, CADD 23.80
- P38S (p.Pro38Ser), gnomAD 15-30904775-C-T, REVEL 0.58, CADD 23.30
- P38A (p.Pro38Ala), gnomAD 15-30904775-C-G, REVEL 0.52, CADD 23.00
- P38P (p.Pro38Pro), gnomAD 15-30904777-A-G, CADD 5.26
- P39S (p.Pro39Ser), 1000Genomes rs183652083, ExAC rs183652083, TOPMed rs183652083, gnomAD rs183652083, REVEL 0.72, CADD 24.20, Uncertain significance, Inborn genetic diseases
- P39L (p.Pro39Leu), gnomAD 15-30904779-C-T, REVEL 0.77, CADD 25.00
- P39P (p.Pro39Pro), rs757766894, gnomAD 15-30904780-T-A, CADD 6.82
- A40G (p.Ala40Gly), rs2061934360, ClinGen CA391519792, ClinVar RCV002623031, ClinVar RCV004750756, REVEL 0.26, CADD 23.50, Uncertain significance, not provided; Karyomegalic interstitial nephritis
- A40T (p.Ala40Thr), ExAC rs774562404, TOPMed rs774562404, gnomAD rs774562404, REVEL 0.30, CADD 22.20, Uncertain significance, Inborn genetic diseases
- A40A (p.Ala40Ala), gnomAD 15-30904783-T-C, CADD 6.11
- K41E (p.Lys41Glu), Ensembl rs1566905469, REVEL 0.45, CADD 26.20
- K41N (p.Lys41Asn), Ensembl rs2061934482
- K41Q (p.Lys41Gln), gnomAD 15-30904784-A-C, REVEL 0.45, CADD 25.70
- L42R (p.Leu42Arg), ExAC rs759899724, gnomAD rs759899724, REVEL 0.74, CADD 28.10
- A43P (p.Ala43Pro), gnomAD 15-30904787-CT-C, CADD 28.40
- A43V (p.Ala43Val), gnomAD 15-30904791-C-T, REVEL 0.45, CADD 25.50
- A43A (p.Ala43Ala), rs200233447, gnomAD 15-30904792-C-T, CADD 11.10
- C44* (p.Cys44Ter), ExAC rs772357075, TOPMed rs772357075, gnomAD rs772357075, CADD 35.00
- C44F (p.Cys44Phe), TOPMed rs1214643381, gnomAD rs1214643381, REVEL 0.96, CADD 29.30
- C44P (p.Cys44Pro), gnomAD 15-30904788-TTGCC, CADD 27.80
- C44C (p.Cys44Cys), rs772357075, gnomAD 15-30904795-C-T, CADD 12.20
- P45S (p.Pro45Ser), gnomAD 15-30904796-C-T, REVEL 0.42, CADD 21.80
- P45T (p.Pro45Thr), gnomAD 15-30904796-C-A, REVEL 0.66, CADD 24.20
- P45P (p.Pro45Pro), gnomAD 15-30904798-C-T, CADD 6.74
- V46I (p.Val46Ile), rs371593413, ESP rs371593413, ExAC rs371593413, gnomAD rs371593413, REVEL 0.09, CADD 0.01, Variant assessed as somatic; moderate impact.
- C47* (p.Cys47Ter), rs144469584, ClinGen CA7449987, ClinVar RCV003421140, ClinVar RCV005012942, CADD 32.00, Pathogenic
- C47R (p.Cys47Arg), NCI-TCGA Cosmic COSV6295, cosmic curated COSV62950, Variant assessed as somatic; moderate impact.
- C47C (p.Cys47Cys), rs144469584, gnomAD 15-30904804-C-T, CADD 6.91
- S48N (p.Ser48Asn), Ensembl rs2061935031
- K49* (p.Lys49Ter), gnomAD 15-30904808-A-T, CADD 34.00
- M50I (p.Met50Ile), TOPMed rs1007940466, gnomAD rs1007940466, REVEL 0.42, CADD 23.60, Uncertain significance, Karyomegalic interstitial nephritis
- M50K (p.Met50Lys), 1000Genomes rs148404807, ESP rs148404807, ExAC rs148404807, TOPMed rs148404807, Likely benign
- M50L (p.Met50Leu), ExAC rs749998047, gnomAD rs749998047, REVEL 0.41, CADD 18.80
- M50R (p.Met50Arg), rs148404807, ClinGen CA7449990, cosmic curated COSV10075, ClinVar RCV000879461, REVEL 0.76, CADD 27.40, Conflicting interpretations, Hereditary breast ovarian cancer syndrome; Hereditary cancer; not provided
- M50T (p.Met50Thr), 1000Genomes rs148404807, ESP rs148404807, ExAC rs148404807, TOPMed rs148404807, REVEL 0.71, CADD 25.70, Uncertain significance, Karyomegalic interstitial nephritis
- M50V (p.Met50Val), ExAC rs749998047, gnomAD rs749998047
- V51E (p.Val51Glu), gnomAD 15-30904815-T-A, REVEL 0.80, CADD 29.30
- P52A (p.Pro52Ala), ExAC rs766068846, gnomAD rs766068846, REVEL 0.54, CADD 23.80
- P52S (p.Pro52Ser), ExAC rs766068846, gnomAD rs766068846, REVEL 0.51, CADD 23.30
- P52L (p.Pro52Leu), gnomAD 15-30904818-C-T, REVEL 0.40, CADD 22.40
- R53I (p.Arg53Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R53* (p.Arg53Ter), rs1414561356, gnomAD 15-30904818-C-CT, CADD 24.40
- R53R (p.Arg53Arg), gnomAD 15-30904822-A-G, CADD 10.90
- Y54* (p.Tyr54Ter), gnomAD rs1397244647, CADD 26.20
- Y54C (p.Tyr54Cys), ESP rs376214743, TOPMed rs376214743, gnomAD rs376214743, REVEL 0.60, CADD 25.20
- Y54N (p.Tyr54Asn), gnomAD rs2061935554, REVEL 0.54, CADD 26.10
- D55G (p.Asp55Gly), gnomAD 15-30904827-A-G, REVEL 0.13, CADD 17.40
- L56* (p.Leu56Ter), gnomAD rs1170312334, CADD 37.00
- L56K (p.Leu56Lys), rs1019748777, gnomAD 15-30904828-CTT-C, CADD 28.00
- L56L (p.Leu56Leu), rs1427301217, gnomAD 15-30904829-T-C, CADD 9.03
- N57N (p.Asn57Asn), rs751192352, gnomAD 15-30904834-C-T, CADD 8.61
- R58G (p.Arg58Gly), ExAC rs754760573, gnomAD rs754760573, REVEL 0.27, CADD 19.00, Uncertain significance
- R58L (p.Arg58Leu), NCI-TCGA Cosmic COSV1007, cosmic curated COSV10075, Variant assessed as somatic; moderate impact.
- R58Q (p.Arg58Gln), TOPMed rs2061936152, REVEL 0.09, CADD 11.50, Uncertain significance, Karyomegalic interstitial nephritis
- R58W (p.Arg58Trp), rs754760573, ExAC rs754760573, gnomAD rs754760573, REVEL 0.14, CADD 21.30, Uncertain significance, Karyomegalic interstitial nephritis
- R58R (p.Arg58Arg), rs754760573, gnomAD 15-30904835-C-A, CADD 9.18
- H59L (p.His59Leu), gnomAD rs1394113080
- H59P (p.His59Pro), gnomAD rs1394113080, REVEL 0.93, CADD 27.50
- H59Y (p.His59Tyr), TOPMed rs2061936271
- H59H (p.His59His), rs756187284, gnomAD 15-30904840-C-T, CADD 6.27
- L60F (p.Leu60Phe), gnomAD rs1327730619
- L60H (p.Leu60His), ExAC rs777970369, gnomAD rs777970369, REVEL 0.75, CADD 27.50
- L60I (p.Leu60Ile), gnomAD rs1327730619, REVEL 0.18, CADD 17.50
- D61del (p.Asp61del), rs2061936636, gnomAD 15-30904842-TTGA-, CADD 21.90
- D61G (p.Asp61Gly), gnomAD 15-30904845-A-G, REVEL 0.87, CADD 29.60
- M63I (p.Met63Ile), Ensembl rs2061936766
- M63V (p.Met63Val), ExAC rs749431740, gnomAD rs749431740, REVEL 0.19, CADD 9.96
Public FAN1 analysis runs
- FAN1 analysis run — FAN1 (1,677 variants) — completed 2026-08-22